HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

The vitamin A analogues: 13-cis retinoic acid, 9-cis retinoic acid, and Ro 13-6307 inhibit neuroblastoma tumour growth in vivo.

AbstractBACKGROUND:
Neuroblastoma, a childhood tumour of the sympathetic nervous system, may undergo spontaneous differentiation or regression due to apoptosis after no or minimal therapy. However, the majority of neuroblastomas are diagnosed as metastatic tumours with a poor prognosis in spite of intensive multimodal therapy. Vitamin A and its analogues (retinoic acid, RA) play an important role in normal cel lular differentiation and programmed cell death. RA regulates neuroblastoma growth and differentiation in vitro, and has shown activity against human neuroblastoma in vivo.
PROCEDURE:
Recently, 9-cis RA was shown to induce apoptosis in vitro in neuroblastoma using a 5 days short-term treatment and subsequent washout. In the present study, nude rats with human neuroblastoma SH-SY5Y xenografts were treated with 13-cis RA (4 mg po daily), 9-cis RA (5 mg po daily) or the novel analogue Ro 13-6307 (0.3 mg po daily) using either a continuous or short-term schedule.
RESULTS:
ALL three different retinoids decreased neuroblastoma growth significantly in terms of tumour weight after 8-12 days when compared to untreated controls (P < 0.05). Minor signs of toxicity in 13-cis RA treated rats were observed. However, severe toxicity with significant weight loss was seen in all rats treated with 9-cis RA and Ro 13-6307. Toxicity was more pronounced with the continuous regimen.
CONCLUSIONS:
We conclude that different retinoids reduce neuroblastoma tumour growth in vivo. Drug scheduling and dosage may affect both therapeutic efficacy and toxic side effects. Further in vivo studies are warranted, including pharmacokinetic and molecular analyses, before clinical trials with promising retinoids like 9-cis RA and Ro 13-6307 can be started in children with neuroblastoma.
AuthorsF Ponthan, P Borgström, M Hassan, E Wassberg, C P Redfern, P Kogner
JournalMedical and pediatric oncology (Med Pediatr Oncol) Vol. 36 Issue 1 Pg. 127-31 (Jan 2001) ISSN: 0098-1532 [Print] United States
PMID11464864 (Publication Type: Comparative Study, Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Antineoplastic Agents
  • Fatty Acids, Unsaturated
  • Alitretinoin
  • Tretinoin
  • Ro 13-6307
  • Isotretinoin
Topics
  • Alitretinoin
  • Animals
  • Antineoplastic Agents (administration & dosage, pharmacology, therapeutic use, toxicity)
  • Body Weight (drug effects)
  • Cell Differentiation (drug effects)
  • Cell Division (drug effects)
  • Diarrhea (chemically induced)
  • Drug Administration Schedule
  • Fatty Acids, Unsaturated (administration & dosage, pharmacology, therapeutic use, toxicity)
  • Female
  • Humans
  • Isotretinoin (administration & dosage, pharmacology, therapeutic use, toxicity)
  • Male
  • Mice
  • Neoplasm Transplantation
  • Neuroblastoma (drug therapy, pathology)
  • Rats
  • Rats, Nude
  • Tretinoin (administration & dosage, pharmacology, therapeutic use, toxicity)
  • Tumor Cells, Cultured (transplantation)
  • Xenograft Model Antitumor Assays

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: